Becker's Healthcare October 26, 2021
In Collaboration with hc1

Many believe that precision medicine is the next frontier in healthcare, but the landscape is complicated. With thousands of genetic tests offered in the market today, physicians are frequently unsure what to order and how to interpret the results.

On August 31, panelists discussed precision medicine, the role of diagnostics like pharmacogenomic testing and the intersection of precision health and population health during the first day of the Precision Health Virtual Summit hosted by hc1 and Becker’s Hospital Review.

Presenters were:

  • Brad Bostic, chairman and CEO, hc1
  • Mitch Daniels, president, Purdue University in West Lafayette, Ind.
  • David B. Nash, MD, founding dean emeritus, Jefferson College of Population Health in Philadelphia
  • Robert Michel, editor-in-chief, DARK Daily and The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma / Biotech, Precision Medicine, Trends
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article